Tricia Thornton-Wells

Company: Johnson & Johnson

Job title: Senior Director, Compound Development Team Leader

Seminars:

Novel Liposomal Active Immunotherapy Targeting pTau in Alzheimer’s Disease 4:00 pm

Introducing potentially pivotal phase 2b study testing JNJ-64042056 in A+T+ preclinical AD Early learnings and insights from precision medicine approach to pre-screening directly from diverse communities with pT217 Utilizing MOA-based precision neuroimaging measures to quantify spread of tau pathologyRead more

day: Conference Day Two PM